Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adults.

BACKGROUND: COVID-19 caused by SARS-CoV-2 is a great threat to public health. We present the safety and immunogenicity data from a phase I trial in China of an mRNA vaccine (LVRNA009). METHODS: In the single-centre, double-blind, placebo-controlled and dose-escalation study, 72 healthy unvaccinated adults aged 18-59 years were randomized (3:1) to receive LVRNA009 with one of three vaccine dosage (25, 50 and 100 µg) or placebo, to evaluate for the safety, tolerability and immunogenicity of LVRNA009. RESULTS: All these participants received two injections 28 days apart. No adverse events higher than grade 2 were reported during the study. A total of 30 participants (42 %) reported solicited adverse reactions during the first 14 days after vaccinations. Of the events reported, fever (n = 11, 15 %) was the most common systemic adverse reaction, and pain at the injection site (n = 17, 24 %) was the most frequent solicited local adverse reaction. Anti-S-protein IgG and neutralising antibodies were observed to have been induced 14 days after the first dose, significantly increased 7 days after the second dose, and remained at a high level 28 days after the second dose. Specific T-cell responses peaked 7 days and persisted 28 days after second vaccination. CONCLUSION: LVRNA009 has demonstrated promising results in safety and tolerability at all three dose levels among Chinese adults. LVRNA009 at three dose levels could rapidly induce strong humoral and cellular immune responses, including binding and neutralising antibody production and IFN- γ secretion, which showed good immunogenicity. CLINICAL TRIAL REGISTRATION NUMBER: Clinicaltrials.gov NCT05364047; Chictr.org.cn ChiCTR2100049349.

Preparation of bio-jet fuels by a controllable integration process: Coupling of biomass fermentation and olefin polymerization.

This work demonstrated that bio-jet fuels can be directionally prepared from bagasse (a typical lignocellulose biomass) by integrating bio- and chemical catalysis reaction processes. This controllable transformation started with the preparation of acetone/butanol/ethanol (ABE) intermediates through the enzymolysis and fermentation of bagasse. Pretreatment of bagasse by deep eutectic solvent (DES) promoted the enzymatic hydrolysis and fermentation because it destroyed the structure of biomass and remove lignin in lignocellulose. Subsequently, the selective catalytic conversion of sugarcane derived ABE broth to jet range fuels was achieved through an integrated process: ABE dehydration to light olefins over the HSAPO-34 catalyst and olefin polymerization to bio-jet fuels over the Ni/HBET catalyst. The dual catalyst bed synthesis mode improved the selectively of bio-jet fuels. High selectivity of jet range fuels (83.0 %) and high conversion of ABE (95.3 %) were obtained by the integrated process.

Analytical Determination of Static Deflection Shape of an Asymmetric Extradosed Cable-Stayed Bridge Using Ritz Method.

A practical method to analyze the mechanical behavior of the asymmetric extradosed cable-stayed (AECS) bridge is provided in this paper. The work includes the analysis of the equivalent membrane tension of the cables, the ratio of side-span cable force to middle-span cable force, and the deflection of the main girder subject to uniformly distributed load. The Ritz method is a simple and efficient way to solve composite structures, such as the AECS bridge, compared with the traditional force method, displacement method, or finite element method. The theoretical results obtained from the Ritz method are in good agreement with that from the finite element analysis, which shows the accuracy of this approach. Then, a parametric study of AECS bridges is carried out by using the proposed equations directly, instead of using the traditional finite element modeling process, which requires a lot of modeling work. As a result, reasonable values of very important parameters are suggested, which helps the readers reach a better understanding of the mechanical behavior of AECS bridges. More importantly, it helps the designers to enhance the efficiency in the stage of conceptual design.

The cubital tunnel syndrome caused by intraneural ganglion cyst of the ulnar nerve at the elbow: a case report.

BACKGROUND: Cubital tunnel syndrome is common nerve compression syndrome among peripheral nerve compression diseases. However, the syndrome caused by intraneural ganglion cysts has been rarely reported. Medical approaches, like ultrasound-guided aspiration and open surgical treatment remain to be discussed. CASE PRESENTATION: A 57-year-old woman presented with occasional pain, numbness and paralysis in her left hand and a palpable, painless mass in the ulnar side of her left elbow. Ultrasound-guided aspiration of the mass was performed to decompress the ulnar nerve. The patient experienced an evident release of pain in her hand, but symptoms of numbness and paralysis recurred 3 months later which greatly bothered the patient's daily life. After evaluation, we had to perform an open surgery to excise the cyst. External neurolysis and anterior subcutaneous transposition were done. The patient was followed up for 2 years, and she made a complete recovery with no functional limitation. CONCLUSIONS: The symptoms caused by intraneural ganglion cyst can be alleviated by accurate puncture. But puncture may be not complete and symptoms could recur. Complete external neurolysis can be counted as a complete and reliable treatment. Therefore, early diagnosis, careful preoperative imaging assessment and full decompression can be expected to receive a good rehabilitation.

Human cytomegalovirus and Epstein-Barr virus infections, risk factors, and their influence on the liver function of patients with acute-on-chronic liver failure.

BACKGROUND: Studies on human cytomegalovirus (HCMV) and Epstein-Barr virus (EBV) have focused primarily on the immunosuppressed population. Few studies have considered immunocompetent and not severely immunocompromised patients. We determined the infection rates of HCMV and EBV, their risk factors and their influence on liver function in patients with HBV-related acute-on-chronic liver failure (ACLF). METHODS: Patients infected with ACLF-based hepatitis B virus (HBV) from 1 December 2016 to 31 May 2018 were enrolled in our study and were divided into infected and uninfected groups. The risk factors for HCMV and EBV infection and their influence on liver function were analysed. RESULTS: A total of 100 hospitalized patients with ACLF due to HBV infection were enrolled in this study. Of these patients, 5% presented HCMV deoxyribonucleic acid (DNA) and 23.0% presented EBV DNA. An HBV DNA count of < 1000 IU/mL increased the occurrence of HCMV infection (P = 0.003). Age, especially older than 60 years, was a risk factor for EBV infection (P = 0.034, P = 0.033). HCMV-infected patients had lower alanine aminotransferase (ALT) levels; albumin levels and Child-Pugh scores in EBV-infected patients were higher than those in uninfected patients. CONCLUSIONS: HCMV and EBV were detected in patients with ACLF caused by HBV infection. Lower replication of HBV (HBV DNA < 1000 IU/mL) may increase the probability of HCMV infection; age, especially older than 60 years of age, was a risk factor for EBV infection. HCMV infection may inhibit HBV proliferation and did not increase liver injury, while co-infection with EBV may influence liver function and may result in a poor prognosis.